Similarity of marks
By Edy Guadalupe Portal, Portal & Asociados
The English company, Glaxo Group Limited, filed an application to register EPIVIR for pharmaceutical products. The National Bureau of Registries confirmed the denial of registration by the Intellectual Property Department because of the mark´s similarity to the previously registered mark EPIVIEW registered by E.R. Squibb & Sons Inc. for similar goods.